• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(腺苷二磷酸核糖)聚合酶抑制剂对新制癌菌素诱导的HeLa-S3细胞G2期延迟的影响。

Effect of poly(adenosine diphosphate-ribose) polymerase inhibitors on neocarzinostatin-induced G2 delay in HeLa-S3 cells.

作者信息

Iseki S, Mori T

出版信息

Cancer Res. 1985 Sep;45(9):4224-8.

PMID:2992774
Abstract

The antitumor antibiotic neocarzinostatin (NCS), which produces single-strand breaks in mammalian cell DNA in vivo, stimulated the activity of chromatin bound enzyme, poly(ADP-ribose) polymerase in HeLa-S3 cells. Because of the possible causal relationship between the poly ADP-ribosylation of chromatin protein and NCS-induced temporary G2 arrest in the cell cycle, several classes of inhibitors of poly(ADP-ribose) polymerase were examined to evaluate the effect on NCS-induced polymerase activity as well as on progression in the cell cycle of synchronized HeLa cells which had been treated with NCS in G2. Compared at the same concentration of 2 mM, the polymerase-inhibiting activity was larger in the order of thymidine, 3-aminobenzamide, nicotinamide, theophylline, and caffeine. Among these agents, caffeine, theophylline, and thymidine caused a reduction in the G2 delay in this order by stimulating the cells to undergo mitosis after NCS treatment. However, 3-aminobenzamide and nicotinamide were poor reducers, if any, of NCS-induced G2 delay. These results suggest that there is not a direct involvement of poly ADP-ribosylation of chromatin protein in the mechanism of NCS-induced G2 delay. The effect of caffeine on G2 delay will probably be independent of its activity as a poly(ADP-ribose) polymerase inhibitor.

摘要

抗肿瘤抗生素新制癌菌素(NCS)能在体内使哺乳动物细胞DNA产生单链断裂,它可刺激HeLa-S3细胞中与染色质结合的酶——聚(ADP-核糖)聚合酶的活性。鉴于染色质蛋白的聚ADP-核糖基化与NCS诱导的细胞周期中暂时的G2期阻滞之间可能存在因果关系,研究了几类聚(ADP-核糖)聚合酶抑制剂,以评估其对NCS诱导的聚合酶活性以及对在G2期用NCS处理过的同步化HeLa细胞的细胞周期进程的影响。在相同浓度2 mM下比较,聚合酶抑制活性大小依次为胸苷、3-氨基苯甲酰胺、烟酰胺、茶碱和咖啡因。在这些试剂中,咖啡因、茶碱和胸苷通过刺激细胞在NCS处理后进行有丝分裂,依次导致G2期延迟缩短。然而,3-氨基苯甲酰胺和烟酰胺对NCS诱导的G2期延迟的缩短作用(如果有的话)很差。这些结果表明,染色质蛋白的聚ADP-核糖基化在NCS诱导的G2期延迟机制中并非直接参与。咖啡因对G2期延迟的影响可能与其作为聚(ADP-核糖)聚合酶抑制剂的活性无关。

相似文献

1
Effect of poly(adenosine diphosphate-ribose) polymerase inhibitors on neocarzinostatin-induced G2 delay in HeLa-S3 cells.聚(腺苷二磷酸核糖)聚合酶抑制剂对新制癌菌素诱导的HeLa-S3细胞G2期延迟的影响。
Cancer Res. 1985 Sep;45(9):4224-8.
2
Effects of caffeine on neocarzinostatin-induced inhibition of cell cycle traverse in HeLa-S3 cells.咖啡因对新制癌菌素诱导的HeLa-S3细胞周期进程抑制的影响。
Cancer Res. 1980 Oct;40(10):3786-91.
3
Neocarzinostatin-induced DNA strand scission and subsequent cell cycle traverse in HeLa S3 cells.
Cancer Res. 1980 Jul;40(7):2405-10.
4
Caffeine-induced recovery from G2 block caused by neocarzinostatin.咖啡因诱导的由新制癌菌素引起的G2期阻滞的恢复。
Gan. 1980 Aug;71(4):567-71.
5
Diverse effects of ADP-ribosyl transferase inhibitors on G2 progression and lethality in Chinese hamster ovary cells damaged by DNA-interfering agents.ADP-核糖基转移酶抑制剂对DNA干扰剂损伤的中国仓鼠卵巢细胞G2期进程和致死率的不同影响。
Jpn J Exp Med. 1988 Apr;58(2):99-107.
6
Poly(ADP-ribose) and the response of cells to ionizing radiation.聚(ADP - 核糖)与细胞对电离辐射的反应
Radiat Res. 1985 Jan;101(1):29-46.
7
Specificity of inhibitors of poly(ADP-ribose) synthesis. Effects on nucleotide metabolism in cultured cells.聚(ADP - 核糖)合成抑制剂的特异性。对培养细胞中核苷酸代谢的影响。
Mol Pharmacol. 1985 Aug;28(2):200-6.
8
Influence of inhibitors of poly(ADP-ribose) polymerase on DNA repair, chromosomal alterations, and mutations.聚(ADP - 核糖)聚合酶抑制剂对DNA修复、染色体改变及突变的影响。
Princess Takamatsu Symp. 1983;13:227-42.
9
Inhibition of formation of microtubular paracrystals in HeLa-S3 cells by neocarzinostatin.新制癌菌素对HeLa-S3细胞中微管副晶体形成的抑制作用。
Cancer Res. 1975 Dec;35(12):3705-9.
10
Antitumor mechanisms of zinostatin stimalamer (YM881).新制癌菌素斯替马兰(YM881)的抗肿瘤机制。
Res Commun Mol Pathol Pharmacol. 1996 May;92(2):165-76.